Clinical trial · Observational
Fertility Decision and Outcomes in Young Women With Breast Cancer
NCT07804745CI-TRIAL-00126045active not recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 26, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260926-000001
Summary
Brief summary (as posted)
This observational study is to learn about the fertility outcomes and decision after breast cancer diagnosis, and the current status of fertility consultation and decision support in young women diagnosed with breast cancer in China.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer - Female | Breast Neoplasm | PROBABILISTIC | 0.70 |
| Fertility | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| No intervention (observational study) | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Case Group (No childbearing after diagnosis)
- description
- Patients diagnosed with breast cancer who had no live birth prior to diagnosis but had no live birth after diagnosis.
- interventionNames
- Other: No intervention (observational study)
- label
- Control Group (Childbearing after diagnosis)
- description
- Patients diagnosed with breast cancer who had no live birth prior to diagnosis but had at least one live birth after diagnosis.
- interventionNames
- Other: No intervention (observational study)
Primary outcomes (1)
- measure
- Childbearing after breast cancer diagnosis
- timeFrame
- Up to 2026
- description
- We will follow up with patients who had not given birth before their cancer diagnosis, to establish whether they had given birth by the end of follow-up. It will be assessed by patient self-report during follow-up and available medical records. The outcome will be recorded as a binary variable (yes/no).
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 40 Years
Show eligibility criteria text
Inclusion Criteria: * Female breast cancer patients, aged 18-40 years at diagnosis. * Treated at the three participating hospitals between 1 January 2013 and 31 December 2023. * Complete clinical documentation available in the electronic medical record system. * Had no child before cancer diagnosis. Exclusion Criteria: * Prior reproductive compromise (surgical or diagnostic infertility or pre-existing infertility factors) before cancer diagnosis. * Presented with de novo stage IV (metastatic) disease. * Had a history of other malignancies. * Patients who refuse to participate or cannot be contacted for follow-up.
References
Publications (0)
Data not yet available
No reference posted for this study.